Tyra Biosciences, Inc.TYRANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-35.27%
↑ 58% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-84.35%
Historical baseline
PeriodValue
2025-35.27%
2024-38.36%
2023-0.13%
2022-108.33%
2021-202.24%
2020-206.10%
20190.00%